Literature DB >> 21971285

Connective tissue diseases: Predicting death in SSc: planning and cooperation are needed.

Robyn T Domsic, Thomas A Medsger.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21971285      PMCID： PMC3544157          DOI： 10.1038/nrrheum.2011.152

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Changes in causes of death in systemic sclerosis, 1972-2002.

Authors:  Virginia D Steen; Thomas A Medsger
Journal:  Ann Rheum Dis       Date:  2007-02-28       Impact factor: 19.103

Review 2.  Validation, updating and impact of clinical prediction rules: a review.

Authors:  D B Toll; K J M Janssen; Y Vergouwe; K G M Moons
Journal:  J Clin Epidemiol       Date:  2008-11       Impact factor: 6.437

3.  Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.

Authors:  S I Nihtyanova; E C Tang; J G Coghlan; A U Wells; C M Black; C P Denton
Journal:  QJM       Date:  2009-12-04

Review 4.  Clinical prediction rules. A review and suggested modifications of methodological standards.

Authors:  A Laupacis; N Sekar; I G Stiell
Journal:  JAMA       Date:  1997-02-12       Impact factor: 56.272

5.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

6.  Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres.

Authors:  J Fransen; D Popa-Diaconu; R Hesselstrand; P Carreira; G Valentini; L Beretta; P Airo; M Inanc; S Ullman; A Balbir-Gurman; S Sierakowski; Y Allanore; L Czirjak; V Riccieri; R Giacomelli; A Gabrielli; G Riemekasten; M Matucci-Cerinic; D Farge; N Hunzelmann; F H J Van den Hoogen; M C Vonk
Journal:  Ann Rheum Dis       Date:  2011-07-21       Impact factor: 19.103

7.  What do we mean by validating a prognostic model?

Authors:  D G Altman; P Royston
Journal:  Stat Med       Date:  2000-02-29       Impact factor: 2.373

8.  Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population.

Authors:  C Bryan; Y Howard; P Brennan; C Black; A Silman
Journal:  Br J Rheumatol       Date:  1996-11

Review 9.  Clinical prediction rules. Applications and methodological standards.

Authors:  J H Wasson; H C Sox; R K Neff; L Goldman
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

10.  Determinants of morbidity and mortality of systemic sclerosis in Canada.

Authors:  Firas F Al-Dhaher; Janet E Pope; Janine M Ouimet
Journal:  Semin Arthritis Rheum       Date:  2008-08-15       Impact factor: 5.532
  10 in total
  2 in total

Review 1.  [Autologous stem cell transplantation in systemic sclerosis].

Authors:  J C Henes; S Wirths; I Kötter
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

2.  Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

Authors:  M C Oliveira; M Labopin; J Henes; J Moore; N Del Papa; A Cras; I Sakellari; R Schroers; H U Scherer; A Cuneo; S Kyrcz-Krzemien; T Daikeler; T Alexander; J Finke; M Badoglio; B Simões; J A Snowden; D Farge
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.